Sahota, Manisha
Saraskani, Sepas Ryan
Xu, Hao
Li, Liandong
Majeed, Abdul Wahab
Hermida, Uxio
Neubauer, Stefan
Desai, Milind
Weintraub, William
Desvigne-Nickens, Patrice
Schulz-Menger, Jeanette
Kwong, Raymond Y.
Kramer, Christopher M.
Young, Alistair A.
Lamata, Pablo
,
Funding for this research was provided by:
UK Research and Innovation (104691, 104691)
Wellcome / EPSRC Centre for Medical Engineering (WT203148/Z/16/Z, WT203148/Z/16/Z, WT203148/Z/16/Z)
National Heart, Lung, and Blood Institute (U01HL117006-01A1, U01HL117006-01A1)
NIHR Oxford Biomedical Research Centre
Wellcome Trust (209450/Z/17/Z)
Article History
Received: 7 April 2022
Accepted: 30 August 2022
First Online: 6 October 2022
Declarations
:
: Dr. Neubauer has been a consultant for Pfizer and Cytokinetics; and has received research grants from Boehringer Ingelheim. Dr. Kwong has received research support from Siemens Healthineers, Bayer AG, and MyoKardia. Dr. Schulz-Menger has been a consultant for Bayer; and has received research grants from Bayer, Siemens Healthineers, and Circle Cardiovascular Imaging. Dr Weintraub has been a consultant for Amarin, Janssen, AstraZeneca, and SC Pharma, and has received research grants from Amarin. Dr. Kramer has been a consultant for Cytokinetics; and has received research grants from Biotelemetry and MyoKardia. Other authors have nothing to disclose.
: Ethical approval was obtained.
: All participants gave informed consent.
: No identifiable individual information was included in this study.